Asensus, NVIDIA Team Up to Boost ISU Augmented Intelligence

Asensus Surgical began a collaboration with NVIDIA to accelerate development of Asensus’ Intelligent Surgical Unit (ISU) and improve its ability to deliver novel clinical intelligence.
 
NVIDIA’s broad suite of augmented intelligence tools aim to enhance the ISU’s capabilities. Asensus’ ISU is built with NVIDIA accelerated computing tech, which has brought digital tags, 3D measurement, and enhanced camera control to surgeons since 2021.
 
“We’re thrilled to collaborate with NVIDIA to enhance the machine vision and image analytics capabilities of the ISU, as well as the processing speed and precision of its augmented intelligence capabilities. Utilizing NVIDIA’s advanced technologies will allow us to further improve the ISU’s augmented intelligence capabilities and the roadmap of our innovative clinical applications,” Anthony Fernando, Asensus president and CEO told the press. “Through this collaboration, Asensus is furthering its vision to enhance clinical intelligence in surgery through the use of advanced augmented intelligence tools.”
 
Both companies will have access to product roadmaps, and the two plan to jointly define business models for digital surgical solutions development, deployment, and commercialization.
 
“The healthcare industry, and in particular digital surgery, is becoming one of the largest data generating industries. NVIDIA brings a domain-specific full stack edge AI computing platform, Holoscan, to medtech innovators looking to optimize real-time data and image processing to help solve complex problems and improve surgeon decision-making,” said David Niewolny, director of healthcare business development at NVIDIA. “As a leading FDA cleared solution in soft-tissue abdominal surgery, Asensus’s ISU is a perfect platform to leverage NVIDIA’s software-defined architecture to accelerate innovation and deliver new products to surgeons faster via software-as-a-medical-device applications.”